Skip to main content
NIH funding notice RFA-DA-17-024

Optimizing the HIV Care Continuum for Substance Abusing Populations at High-Risk and/or Living with HIV (R01)

Closed on May 9, 2017.

Posted
December 6, 2016
Close date
May 9, 2017
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,752,120 in first-year total cost, median $876,060.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 HXO-H (10)]2

Most frequent institutions

  1. BOSTON MEDICAL CENTER1
  2. JOHNS HOPKINS UNIVERSITY1
Competing awards under RFA-DA-17-024 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2017Building on Needle Exchange to Optimize HIV Prevention/Treatment1R01DA045556-01LUCAS, GREGORY MPAGE, KATHLEEN RJOHNS HOPKINS UNIVERSITY, MD$955,194ZDA1
2017Linking Russian Narcology and HIV Care to Enhance Treatment, Retention and Outcomes Part II1R01DA045547-01SAMET, JEFFREY H.BOSTON MEDICAL CENTER, MA$796,926ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.